Washington Editor, BioCentury, Co-host, BioCentury This Week television. Author: Engineering Communism, How Two Americans Spied for Stalin...

Search Tweets

Twitter Feed

@steveusdin1 — 1,192 followers, 1,562 tweets

PTAB: Orange Book patents survive best among tech IPRs. FDA-approved drugs have fared markedly better against PTAB challenges than other technology related patents.  https://www.biocentury.com/bc-extra/politics-policy/2018-03-16/ptab-orange-book-patents-survive-best-among-tech-iprs 
ICER draft: prices of two of three cystic fibrosis drugs from Vertex Pharmaceuticals Inc. ($VRTX) would need to be discounted by about half for the drugs to be cost-effective.  https://www.biocentury.com/bc-extra/politics-policy/2018-03-16/icer-draft-some-vertex-cf-drug-prices-should-be-halved 
RT @BenWKnowles89: I have been asked to share this by a CF mum not on social media. She has sent this to her local MP. Please share an… https://t.co/bbdg7zmpNz
RT @FishburnSimone: In case you needed any more convincing that biotech is taking off in China. @bradloncar is on it.  https://twitter.com/BioCentury/status/974050180394823680 
Show More